Aplastic anemia secondary to azathioprine in systemic lupus erythematosus: report of a case with normal thiopurine S-methyltransferase enzyme activity and review of the literature

Azathioprine-induced aplastic anemia and fatal myelosuppression is a rare occurrence in patients with systemic lupus erythematosus (SLE). We report a case of a 53-year-old female with a normal thiopurine S-methyltransferase (TPMT) level who developed aplastic anemia within 4 weeks of azathioprine in...

Full description

Saved in:
Bibliographic Details
Published inLupus Vol. 22; no. 14; pp. 1526 - 1528
Main Authors Yeter, KC, Afkhami, M, Brynes, RK, Quismorio, FP
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.12.2013
Sage Publications Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Azathioprine-induced aplastic anemia and fatal myelosuppression is a rare occurrence in patients with systemic lupus erythematosus (SLE). We report a case of a 53-year-old female with a normal thiopurine S-methyltransferase (TPMT) level who developed aplastic anemia within 4 weeks of azathioprine initiation, resulting in death. Physicians should be vigilant in monitoring routine blood work when administering azathioprine, a relatively common drug, in patients with SLE.
Bibliography:ObjectType-Case Study-3
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Review-1
ObjectType-Feature-5
ObjectType-Report-2
ObjectType-Article-4
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0961-2033
1477-0962
DOI:10.1177/0961203313504636